Related Experiment Video
Updated: Jun 20, 2026
Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
Toll-like receptors in multiple sclerosis mouse experimental models
1Neuroimmunology, Neuroscience Centre, ICMS, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. m.calado-marta@qmul.ac.uk
Abstract:
Certain pathogen molecules trigger innate immune responses and drive subsequent adaptive immune responses toward an antigen presented simultaneously. Such bacterial or viral molecules constitute pathogen-associated molecular patterns (PAMPs) that bind to pattern-recognition receptors such as toll-like receptors (TLRs). Recently, endogenous molecules were identified that ligate the same receptors. The role of these receptors' response to complete Freund's adjuvant during initiation of CD4 T cell responses in EAE, the animal model for multiple sclerosis, is here discussed. Myeloid differentiation primary response gene 88 (MyD88) is necessary for the induction of experimental autoimmune encephalomyelitis (EAE), and it is required for the activation of myeloid dendritic cells and differentiation of T helper 17 cells. The role of individual TLR, in particular TLR3, TLR4, and TLR9, signaling in modulation of EAE inflammation varies with the experimental model employed and the immune cells that drive pathology. The TLR-dependent production of proinflammatory cytokines is regulated by mechanisms that dampen the pathway and prevent excess damage. Development of TLR antagonists to treat autoimmune diseases must acknowledge the possibility of interference with regulatory mechanisms.
Insights
Pathogen-associated molecular patterns (PAMPs) binding to toll-like receptors (TLRs) initiate immune responses. This study examines TLRs
Area of Science:
- Immunology
- Neuroscience
- Molecular Biology
Background:
- Pathogen-associated molecular patterns (PAMPs) bind to pattern-recognition receptors like toll-like receptors (TLRs), initiating innate and adaptive immunity.
- Endogenous molecules also activate these TLRs, suggesting a role in autoimmune conditions.
- Experimental autoimmune encephalomyelitis (EAE) serves as a model for multiple sclerosis (MS).
Purpose of the Study:
- To investigate the role of toll-like receptors (TLRs) and Myeloid differentiation primary response gene 88 (MyD88) in the initiation of CD4 T cell responses in EAE.
- To understand how TLR signaling influences inflammation and T helper 17 cell differentiation in the context of EAE.
- To explore the implications for developing TLR antagonists for autoimmune diseases.
Main Methods:
- Utilizing the EAE animal model for multiple sclerosis.
- Assessing the necessity of Myeloid differentiation primary response gene 88 (MyD88) for EAE induction.
- Analyzing the function of specific TLRs (TLR3, TLR4, TLR9) in modulating EAE inflammation and immune cell activation.
Main Results:
- Myeloid differentiation primary response gene 88 (MyD88) is essential for EAE induction, myeloid dendritic cell activation, and T helper 17 cell differentiation.
- The impact of individual TLR signaling on EAE inflammation is dependent on the specific experimental model and the immune cells involved.
- TLR-mediated production of pro-inflammatory cytokines is subject to regulatory mechanisms that prevent excessive tissue damage.
Conclusions:
- Myeloid differentiation primary response gene 88 (MyD88) plays a critical role in the pathogenesis of EAE.
- Targeting specific TLRs for autoimmune disease treatment requires careful consideration of their complex roles and regulatory feedback loops.
- Future development of TLR antagonists must account for potential interference with crucial immune regulatory pathways to avoid unintended consequences.
